Replies to post #219 on Vanda Pharmaceuticals, Inc. (VNDA)

[surf1944]

7:22AM On The Wires (WIRES) : Vanda Pharmaceuticals (VNDA) has acquired an exclusive world-wide license from Eli Lilly (LLY) to develop and commercialize a small molecule neurokinin 1 receptor antagonist for all human indications.